ICH: Updated Q9(R1) Briefing Pack

02.04.2026

News

The ICH has fully revised the Q9(R1) Briefing Pack (March/April 2026) to align with the updated ICH Q9 guideline.

Together with ICH Q8(R2) and ICH Q10, Q9(R1) forms the foundation for science- and risk-based quality approaches.

The guideline continues to emphasise two core principles of Quality Risk Management:

risk evaluation based on scientific knowledge with a focus on patient protection

level of effort and documentation commensurate with the level of risk

The updated Briefing Pack includes 18 fully revised training materials and a new presentation on supply chain risk management, covering QRM methods and their applications.

Source:

ICH: News

Meet the GMP Compliance Adviser

The GMP Compliance Adviser is the world's largest knowledge portal for quality management in the pharma business.

The demo access is non-binding and ends automatically.

Test it now for free

You may also be interested in the following articles:

Swissmedic Updates Guidance on GMP Compliance of Foreign Manufacturers

11.09.2026

News

Swissmedic Updates Guidance on GMP Compliance of Foreign Manufacturers

Swissmedic has revised its guidance document “GMP compliance by foreign manufacturers”. The new Version 7.0 has been valid since 7 September 2026. In particular, it introduces new provisions for demonstrating the GMP compliance of manufacturers inspected by the US FDA.

Swissmedic Updates Requirements for Cooperation with Pre-Wholesalers

11.09.2026

News

Swissmedic Updates Requirements for Cooperation with Pre-Wholesalers

Swissmedic has revised its Technical Interpretation “Market release and distribution in cooperation with a pre-wholesaler”. The document addresses market release and distribution where a Marketing Authorisation Holder works with a pre-wholesaler (logistics and distribution service provider).

11.09.2026

News

IPEC Updates Two Guides on Pharmaceutical Excipients

The IPEC Federation has updated two key guides on pharmaceutical excipients. The IPEC Composition Guide for Pharmaceutical Excipients (Version 3, 2026) describes an approach for manufacturers to establish excipient composition profiles. The revised version now covers biotechnology- and fermentation-derived excipients, provides further details on component types and physicochemical characterisation, and includes an example composition profile template.

Applying the FDA’s 7-Step Model for AI/ML Validation in GMP Environments: One Year Later

07.09.2026

LOGFILE Feature

Applying the FDA’s 7-Step Model for AI/ML Validation in GMP Environments: One Year Later

Artificial intelligence is becoming increasingly important in GMP-regulated environments, presenting companies with new regulatory challenges. This article summarizes the latest regulatory developments, introduces a validation framework based on the FDA's seven-step model, and outlines initial practical experience with AI/ML validation.

07.09.2026

Question of the Week

What are the General Requirements for Standard Documents?

Here's the answer:

04.09.2026

News

EDQM: Revised Guidance on Sister File Applications

The European Directorate for the Quality of Medicines & HealthCare (EDQM) has revised its Guidance on applications for “sister files” (PA/PH/CEP (09) 141). The revision is intended to support consistent application of the procedure and provide greater clarity on the classification and assessment of the corresponding CEP applications.